Tozaro is a biotech company leveraging molecular modelling and machine learning (ML) to design and develop stable and cost-effective polymers that bind to gene therapy vectors specifically & selectively. The Smart Polymer™ platform utilises >500 chemical groups to develop specific binding compounds, compared to traditional technologies using proteins and peptides, which use ca. 20 amino acids. Tozaro is able to mine a huge new chemical space using cost-effective Smart Polymers™
Tozaro: Venture Capital Funding History
Tozaro
- Health
- Bedfordshire, United Kingdom
- £6m
- tozaro.com
- Update Information
More venture news
- 30 Sept 2026

Inovus MedicalInovus Medical lands £7m extension led by PXN Group to provide surgeons with surgical simulation training
EquityHealth - 29 Sept 2026

DYADDYAD secures a £7.5m Series A led by Sangha Capital for its system that converts clinical documents into structured data for GP patient records
Series AHealth - 24 Sept 2026

IMS SolutionsIMS Solutions raises a £1.1m seed round led by Midlands Mindforge to develop steroid tests for cancer and PMOS
SeedHealth
